Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. (2022). Clinics, 76, e2587. https://doi.org/10.6061/clinics/2021/e2587 (Original work published 2021)